The treatment of Cataracts & Floaters with vitamins

Cataracts and Floaters: Mitamins custom make quality formulas for the treatment of Cataracts & Floaters with vitamins. A Cataracts & Floaters formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Cataracts and Floaters

  • Amount Per Serving
    % DV
    Vitamin A
    2500
    IU
    50%
    Vitamin C
    100
    mg
    167%
    Vitamin E
    100
    IU
    333%
    Riboflavin
    75
    mg
    4412%
    Selenium
    200
    mcg
    286%
    Alpha Lipoic Acid
    50
    mg
    *
    Lutein
    6000
    mcg
    *
  • Amount Per Serving
    % DV
    Bilberry Extract
    50
    mg
    *
    Ginkgo Extract
    40
    mg
    *
    Grape Seed Extract
    25
    mg
    *
    L-Methionine
    200
    mg
    *
    Carotenoid Complex
    2500
    IU
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice

Cataracts and Floaters Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
American College Of Physicians Expressed 'Great Disappointment' In Veto Of SCHIP Legislation
Internal medicine physicians and medical students today expressed their great disappointment in President Bush's veto of the bipartisan legislation to reauthorize the State Children's Health Insurance Program (SCHIP). The sentiment was expressed in a letter sent to the White House by David C. Dale, MD, FACP, president of the American College of Physicians (ACP).On behalf of the 124,000 internal medicine physicians and medical student members of ACP, Dr.
Cerimon Pharmaceuticals Initiates Phase I Clinical Study Of Topical Diclofenac Sodium Patch
Cerimon Pharmaceuticals, Inc., announced it has initiated a Phase I clinical study of a novel diclofenac sodium patch, the Company's lead pain asset. The study will evaluate safety, tolerability, and systemic pharmacokinetics of a topical patch formulation of diclofenac sodium, a non-steroidal anti-inflammatory drug (NSAID), in 16 healthy volunteers. The Phase I study is expected to be completed in the fourth quarter of 2007.
This information concerning the support of Cataracts and Floaters treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments